Hepatitis C, insulin resistance and fatty liver: Bad things come in threes
AA Abdo, SS Lee
Canadian Journal Of Gastroenterology
June 2012, Volume 26 Issue 6: 323-323
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
No comments:
Post a Comment